Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,496.28 78.75 0.55%
TOPIX 1,170.73 4.14 0.35%
HANG SENG 22,760.24 64.23 0.28%

HCA Announces Secondary Offering



  HCA Announces Secondary Offering

Business Wire

NASHVILLE, Tenn. -- February 11, 2013

HCA Holdings, Inc. (the “Company”) (NYSE: HCA) today announced that certain of
its stockholders, consisting principally of affiliates of, or funds sponsored
by, Bain Capital Partners, LLC and Kohlberg Kravis Roberts & Co. (the “Selling
Stockholders”), intend to offer for sale in an underwritten at-the-market
secondary offering approximately 50 million shares of its common stock
pursuant to the Company’s shelf registration statement filed with the
Securities and Exchange Commission. The Selling Stockholders will receive all
of the proceeds from this offering. No shares are being sold by management or
the Company. The last reported sale price of the Company’s common stock on
February 8, 2013 was $37.22 per share. The offering is expected to close on
February 15, 2013, subject to customary closing conditions.

Barclays Capital Inc. and Citigroup Global Markets Inc. will act as
underwriters for the offering.

The Company has filed a registration statement (including a prospectus) with
the SEC for the offering to which this communication relates. Before you
invest, you should read the prospectus in that registration statement and
other documents the Company has filed with the SEC for more complete
information about the Company and this offering. You may obtain these
documents for free by visiting EDGAR on the SEC Web site at: www.sec.gov.
Alternatively, copies of the prospectus supplement and accompanying prospectus
relating to the offering, when available, may be obtained from:

Barclays Capital Inc., Attention Broadridge Financial Solutions, 1155 Long
Island Avenue, Edgewood, NY 11717, or by calling 1-888-603-5847, or by email
at barclaysprospectus@broadridge.com

or

Citigroup, c/o Broadridge Financial Solutions, 1155 Long Island Avenue,
Edgewood, New York 11717, Phone: (800) 831-9146, batprospectusdept@citi.com

This press release shall not constitute an offer to sell or a solicitation of
an offer to buy, nor shall there be any sale of these securities in any state
or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such
state or jurisdiction.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of
the federal securities laws, which involve risks and uncertainties.
Forward-looking statements include statements that do not relate solely to
historical or current facts and can be identified by the use of words like
“may,” “believe,” “will,” “expect,” “project,” “estimate,” “anticipate,”
“plan,” “initiative” or “continue.” These forward-looking statements are based
on our current plans and expectations and are subject to a number of known and
unknown uncertainties and risks, many of which are beyond our control, which
could significantly affect current plans and expectations and our future
financial position and results of operations. These factors include, but are
not limited to, (1) the impact of our substantial indebtedness and the ability
to refinance such indebtedness on acceptable terms, (2) the effects related to
the enactment and implementation of the Budget Control Act of 2011 (“BCA”) and
the outcome of pending negotiations and legislation related to BCA-mandated
spending reductions that include cuts to Medicare payments, (3) the effects
related to the enactment and implementation of the Patient Protection and
Affordable Care Act, as amended by the Health Care and Education
Reconciliation Act (collectively, the “Health Reform Law”), the possible
enactment of additional federal or state health care reforms and possible
changes to the Health Reform Law and other federal, state or local laws or
regulations affecting the health care industry, (4) increases in the amount
and risk of collectibility of uninsured accounts and deductibles and copayment
amounts for insured accounts, (5) the ability to achieve operating and
financial targets, and attain expected levels of patient volumes and control
the costs of providing services, (6) possible changes in the Medicare,
Medicaid and other state programs, including Medicaid upper payment limit
programs or waiver programs, that may impact reimbursements to health care
providers and insurers, (7) the highly competitive nature of the health care
business, (8) changes in service mix, revenue mix and surgical volumes,
including potential declines in the population covered under managed care
agreements, the ability to enter into and renew managed care provider
agreements on acceptable terms and the impact of consumer driven health plans
and physician utilization trends and practices, (9) the efforts of insurers,
health care providers and others to contain health care costs, (10) the
outcome of our continuing efforts to monitor, maintain and comply with
appropriate laws, regulations, policies and procedures, (11) increases in
wages and the ability to attract and retain qualified management and
personnel, including affiliated physicians, nurses and medical and technical
support personnel, (12) the availability and terms of capital to fund the
expansion of our business and improvements to our existing facilities, (13)
changes in accounting practices, (14) changes in general economic conditions
nationally and regionally in our markets, (15) future divestitures which may
result in charges and possible impairments of long-lived assets, (16) changes
in business strategy or development plans, (17) delays in receiving payments
for services provided, (18) the outcome of pending and any future tax audits,
appeals and litigation associated with our tax positions, (19) potential
adverse impact of known and unknown government investigations, litigation and
other claims that may be made against us, (20) our ongoing ability to
demonstrate meaningful use of certified electronic health record technology
and recognize income for the related Medicare or Medicaid incentive payments,
and (21) other risk factors described in our annual report on Form 10-K for
the year ended December 31, 2011 and our other filings with the Securities and
Exchange Commission. Many of the factors that will determine our future
results are beyond our ability to control or predict. In light of the
significant uncertainties inherent in the forward-looking statements contained
herein, readers should not place undue reliance on forward-looking statements,
which reflect management’s views only as of the date hereof. We undertake no
obligation to revise or update any forward-looking statements, or to make any
other forward-looking statements, whether as a result of new information,
future events or otherwise.

Contact:

HCA Holdings, Inc.
Investor Contact:
Mark Kimbrough, 615-344-2688
or
Media Contact:
Ed Fishbough, 615-344-2810
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement